ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,769.40
0.00%
S&P ASX All Technology
3,070.80
-0.59%
Brent Oil
84.75
0.06%
US Dollar vs AUD
1.49945
0.09%
Bitcoin
66,094.68
1.74%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Aerovate Therapeutics Inc (AVTE)

  7. Aerovate Therapeutics Inc (AVTE) News

AVTE Aerovate Therapeutics Inc

1.38
-0.03 (-2.13%)
Pre Market
Last Updated: 22:16:52
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Aerovate Therapeutics Inc AVTE NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.03 -2.13% 1.38 22:16:52
Open Price Low Price High Price Close Price Previous Close
1.41
more quote information »

Recent News

Date Time Source Heading
17/6/202422:35EDGAR2Form 8-K - Current report
17/6/202422:32GLOBEAerovate Therapeutics Announces 24-Week Topline Results from..
15/6/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/6/202408:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/6/202406:01EDGAR2Form 144 - Report of proposed sale of securities
14/6/202406:44EDGAR2Form 144 - Report of proposed sale of securities
11/6/202407:00EDGAR2Form S-3 - Registration statement under Securities Act of..
08/6/202407:00EDGAR2Form 8-K - Current report
22/5/202406:15GLOBEAerovate Therapeutics Presents Baseline Data from the Phase..
18/5/202409:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/5/202406:59EDGAR2Form 144 - Report of proposed sale of securities
14/5/202406:57EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/5/202406:39EDGAR2Form 8-K - Current report
14/5/202406:30GLOBEAerovate Therapeutics Announces First Quarter Financial..
28/3/202400:20GLOBEAerovate Therapeutics to Present Patient Baseline..
26/3/202407:10GLOBEAerovate Therapeutics Announces Full-Year 2023 Financial..
12/3/202409:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202408:37EDGAR2Form 144 - Report of proposed sale of securities
07/3/202400:00GLOBEAerovate Therapeutics Board of Directors Appoints Habib..
28/2/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/2/202410:38EDGAR2Form 144 - Report of proposed sale of securities
10/2/202408:28EDGAR2Form SC 13G - Statement of acquisition of beneficial..
25/1/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202410:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/1/202408:29EDGAR2Form 144 - Report of proposed sale of securities
09/1/202409:11EDGAR2Form S-8 - Securities to be offered to employees in employee..
08/1/202423:59EDGAR2Form 8-K - Current report
30/12/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202309:50EDGAR2Form 144 - Report of proposed sale of securities
23/12/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/12/202308:24EDGAR2Form 144 - Report of proposed sale of securities
16/12/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202308:10EDGAR2Form 144 - Report of proposed sale of securities
08/12/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/11/202310:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202308:13EDGAR2Form 144 - Report of proposed sale of securities
21/11/202308:46EDGAR2Form 8-K - Current report
21/11/202308:45GLOBEAerovate Therapeutics Announces Simultaneous Completion of..
14/11/202300:03EDGAR2Form 8-K - Current report
14/11/202300:00GLOBEAerovate Therapeutics Announces Third Quarter Financial..
04/11/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/9/202308:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/9/202304:05EDGAR2Form 144 - Report of proposed sale of securities
14/8/202322:16EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:10EDGAR2Form 8-K - Current report
14/8/202322:00GLOBEAerovate Therapeutics Announces Second Quarter Financial..

Your Recent History

NASDAQ
AVTE
Aerovate Therapeutics
COIN
FTXHETH
HairyPlotterFTX
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved